Delivering new insights to drive personalized trials

Nephrology

Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution

Engage Fortrea’s regulatory strategy and operational experts for data-driven planning

Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment

Experience matters when choosing a partner

Partner with us

In the last 5 years

178

Nephrology Studies

5,000+

Sites

23,000+

Patients

Dialysis and End Stage Kidney Disease (ESKD)

Glomerular Disease

Chronic Kidney Disease (CKD) and its complications

Pediatric CDK and ESKD

Renal Impairment Studies

Get the latest from Fortrea

We’re sharing our latest news, events, and publications

Webinar

Article

Recent advances in the use of surrogate endpoints in kidney diseases

Read article

Webinar

Dr. Barbara Gillespie co-moderates the Kidney Health Initiative webinar (58 minutes)

View the recording

Why choose Fortrea for your next Nephrology trial?

Hear and apply our lessons learned across the different types of nephrology studies to understand the nuances of sites and recipe for successful trial execution in dialysis vs. rare kidney disease (e.g., Glomerular Disease) vs. common CKD (e.g., Diabetic Kidney Disease) patients
Benefit from our focused training specific to the needs of each type of nephrology study to address issues such as proper 24-hour urine collections, renal biomarker development, PRO collection and central lab monitoring
Harness the dedicated and overlapping expertise of our partners in Clinical Pharmacology Solutions and our Rare and Pediatric Disease colleagues

Renal Impairment Studies Rare Diseases

Get to know us

Barbara S. Gillespie, MD, MMS, FASN Vice President & Therapeutic Strategy Leader

Meet the team

Your agile partner for comprehensive nephrology clinical trials

We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea’s clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.